AliveCor’s Post

I continue to be a big advocate for the opportunities within Digital Health to help solve some of the foundational issues affecting people in healthcare. I think we're starting to look at some inflection points that are making a lot more of the ideas and concepts already out there a lot more viable. Plus, we simply cannot afford as a society to miss out on these efficiency and outcome driving opportunities with everything else we also need to be able to do and fund. When you look at this list from The Medical Futurist, a common denominator to me is just how credible and doable all the opportunities are - NOW! Now, if only the regulatory bureaucracy could catch up, we would have a flurry of new opportunities to increase quality of care and life for millions. #digitalhealth #trends #startup #regulation https://lnkd.in/duSr7qSm

Great ideas aren't worth much. Here's why: For digital health — Evidence is KING. But most founders are wasting time and money on the wrong stuff. “...our fancy AI can empower...identify...enable...optimize...” Ok. Cool story, bro. Show me the data. Otherwise that's not worth much. But a dead-simple app. With rock-solid proof. For something buyers actually care about? Easily worth 10x more. Great digital health founders who actually build profitable products understand this equation. You can become a great one by starting with small-scale, exploratory research. You need daily iteration and validation for months. Not weeks. Get your research game on point. Today. Our crew at Manos Health just collaborated with Roche to show you how, with our "Build, Prove, Launch" framework. Check it out and let me know what you think. 

💥 Groundbreaking innovation does not predict success. As promising as they may be, the vast majority of digital health technologies (DHTs) will fail to scale. Against the backdrop of an increasingly competitive and regulated environment, how can digital health entrepreneurs ensure their companies thrive? Our latest systematic review, published in the Journal of Medical Internet Research, uncovers the key success factors for growth-stage digital health companies. ➡️ Top Success Factors: Financial viability and market demand are essential for ensuring long-term sustainability. Meanwhile, external factors, like regulatory alignment, take on even greater importance in the digital health sector compared to broader tech industries. ➡️ DHT-Specific Insights: Digital health companies uniquely prioritize data security, system interoperability, and regulatory compliance. Success factors also vary across categories: ▪️Digital Therapeutics thrive through close collaboration with healthcare providers, among others. ▪️Health System Software relies on affordability and integration into existing systems. ➡️ Why this matters: This research offers a clear roadmap for entrepreneurs, stakeholders, and researchers to navigate challenges, scale effectively, and drive impactful innovation. 🙏 A big thank you to the co-authors Tobias Kowatsch, Laura Bitomsky, Marcia Nißen, and Christoph Kausch 🔗

Deep Tech startups are focusing mainly in AI, biotechnology, and genetics. 💥 Find out in this complete episode from The Outliers more about the 95 startups that are improving medical attention and treatments with the most advanced science and engineering 🌐 🌟 ➡️ https://lnkd.in/gt-rkHrp #deeptech #innovation #technology #startups #entrepreneurship

Medical breakthroughs are often referred to as radical or revolutionary. At 3M Health Care, we call it something else – science. Watch the video to learn more.

How is #GenAI transforming healthcare navigation? In the final part of her interview with Moira Forbes, Kara Trott, Quantum Health’s Founder, shares how GenAI empowers our Healthcare Warriors® to enhance every step of the member journey. #HealthcareNavigation

Attended Longevity Unlocked featuring Adam Bataineh MD , who shared his experiences in health-tech and longevity innovation. It was interesting to hear about his work with @Span Health and Numenor and his insights on scaling startups and the future of healthcare. Dr. Adam’s discussion ties into his work and apps through their focus on preventative medicine, personalized health insights, and longevity strategies. His apps aim to empower individuals with actionable health data and coaching, which directly aligns with the use of advanced biomarkers and diagnostic tools he discussed. For example: 1. @Span Health likely integrated data-driven insights like visceral fat, liver health, or other biomarkers to provide users with personalized health plans. 2. Numenor as a digital longevity clinic, might leverage these advanced screening tools to develop individualized prevention and longevity strategies for patients, focusing on reducing long-term risks while avoiding unnecessary interventions. His talk provided the broader context for the kinds of health assessments and technologies these apps advocate for, emphasizing the balance between innovation and practicality in healthcare decisions. It also showcased his philosophy of using data and technology to make preventative care both accessible and effective. Thanks to Imperial Entrepreneurs ,MedTech Society and the Oxford Society of Ageing and Longevity for putting this event together. #HealthTech #Longevity #Innovation #StartUps

𝐎𝐧 𝐭𝐡𝐞 𝐜𝐮𝐬𝐩 𝐨𝐟 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐯𝐞 𝐜𝐡𝐚𝐧𝐠𝐞 The life sciences and healthcare industry is steadily evolving through integrating digital health technologies, AI-driven innovations, and personalized medicine. These trends shape a transformative future, enhancing patient care and advancing medical research. Read the exclusive story: https://lnkd.in/g8DhazT9 #life #sciences #healthcare #industry #integrating #digital #health #technologies #evolving #innovations #AI #medicine #medical #research #future #patient

Technology is transforming neurological care, and scaling its applications requires deep knowledge of healthcare systems across the globe. In Intelligent Health.tech latest article, our CEO Jorgen Ellis and Clare Auty Head of Independent Health and Social Care at Browne Jacobson discuss the steps needed to bring neurotech innovations to market. With our AR technology already providing breakthrough treatments for Parkinson’s, Strolll is ready to expand its impact on global health. Learn more about scaling neurotech here: Unlocking Neurotech Innovation https://lnkd.in/eM86-kpw

TC Medtech has been founded with the core vision of identifying bottlenecks and inefficiencies in the delivery of health outcomes, and translating new technologies to meet these needs